BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
|
Back to Search Results |
|
Model Number DB-1216 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Depression (2361); Unspecified Mental, Emotional or Behavioural Problem (4430)
|
Event Date 12/01/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Event date: exact date unknown, event occurred between december 2021 and january 2022.Additional suspect medical device components involved in the event: product family: dbs-linear leads; upn: m365db2202300; model: db-2202-30; serial: (b)(4); batch: 7074539.Product family: dbs-linear leads; upn: m365db2202300; model: db-2202-30; serial: (b)(4); batch: 7074537.
|
|
Event Description
|
It was reported the patient experienced feelings of helplessness due to worsened general condition with depression, desperation, and spontaneous crying.The physician assessed the patient had developed suspected psychic decompensation which was moderate in severity and determined to be possibly related to stimulation and not related to the device or procedure.The patient was admitted to the hospital and treated with medication.The physician also noted the patient had experienced suicidal ideation and a psychotic episode in the past year, and depression in the 4 weeks before enrollment in the clinical study.
|
|
Event Description
|
It was reported the deep brain stimulation (dbs) clinical study patient (a4010 vercise dbs registry) experienced feelings of helplessness due to worsened general condition with depression, desperation, and spontaneous crying.The physician assessed the patient had developed suspected psychic decompensation which was moderate in severity and determined to be possibly related to stimulation and not related to the device or procedure.The patient was admitted to the hospital and treated with medication.The physician also noted the patient had experienced suicidal ideation and a psychotic episode in the past year, and depression in the 4 weeks before enrollment in the clinical study.Additional information received clarified the physician assessed the patient had developed suspected psychiatric decompensation which was moderate in severity.
|
|
Search Alerts/Recalls
|
|
|